What is the initial workup for a patient presenting with hematospermia (blood in semen)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Hematospermia

For men under 40 years with a single episode of hematospermia and no associated symptoms, reassurance and watchful waiting without imaging is appropriate, as this represents a benign self-limited condition in the vast majority of cases. 1

Initial Clinical Assessment

The baseline workup should include:

  • Visual confirmation that blood originates from the patient's ejaculate (not postcoital bleeding from a sexual partner) 1
  • Urinalysis 1, 2
  • Semen analysis 1
  • Complete blood count 1
  • Serum chemistry panel 1
  • Coagulation studies 1
  • Testing for sexually transmitted infections if lower urinary tract symptoms are present 2

Age-Stratified Approach to Further Workup

Men Under 40 Years

No further imaging is needed if:

  • Single episode of hematospermia 1
  • No risk factors (history of cancer, urogenital malformation, bleeding disorders) 2
  • No associated symptoms 1, 2

Proceed with imaging if:

  • Persistent or recurrent hematospermia beyond several weeks 1
  • Associated symptoms (fever, chills, weight loss, bone pain, lower urinary tract symptoms) 2

The most common identifiable cause in this age group is infection, accounting for approximately 40% of cases overall. 3, 1

Men 40 Years and Older

Mandatory initial workup includes:

  • Prostate-specific antigen (PSA) testing even when other causes seem apparent 1
  • Digital rectal examination 2
  • Transrectal ultrasound (TRUS) as the initial imaging modality 1

TRUS demonstrates abnormalities in 82-95% of men with hematospermia and can identify prostatic calcifications, ejaculatory duct or seminal vesicle cysts, benign prostatic hyperplasia, and Cowper gland masses. 1 It is safe, inexpensive, effective, noninvasive, and radiation-free. 3

Iatrogenic causes from urogenital instrumentation (particularly prostate biopsy) are the most common identifiable cause in this age group. 1, 2

Advanced Imaging

MRI is indicated when:

  • TRUS results are negative or inconclusive 1
  • Persistent hematospermia despite negative initial workup 3

MRI offers operator-independent imaging, superior soft tissue contrast, and multiplanar high-resolution anatomic evaluation of the prostate gland, seminal vesicles, ejaculatory ducts, and ampullary portions of the vasa deferentia. 3, 1 It can be performed at 1.5 or 3 Tesla, with 3T offering higher signal-to-noise ratio and improved spatial resolution. 3

Key Differential Diagnoses to Consider

Common benign causes:

  • Prostatic or ejaculatory duct calcifications 1
  • Seminal vesicle or ejaculatory duct cysts 1
  • Benign prostatic hyperplasia 1
  • Infectious or inflammatory conditions (prostatitis, seminal vesiculitis) 3

Must-not-miss diagnoses:

  • Prostate cancer (especially in men ≥40 years) 1
  • Internal pudendal artery hemorrhage 1
  • Ejaculatory duct obstruction 1

Management Approach

Treatment is directed at the underlying cause once identified:

  • Correction of coagulopathy if present 1
  • Antibiotics for infectious/inflammatory causes 2
  • Urologic referral for persistent cases requiring vesiculoscopy (diagnostic accuracy 74.5% versus 45.3% for TRUS alone) 1

Common Pitfalls

Even with modern imaging techniques, some cases remain idiopathic, but reassurance is appropriate after thorough evaluation excludes serious pathology. 1 The key is distinguishing patients who need aggressive workup (age ≥40, persistent/recurrent symptoms, associated symptoms) from those who can be safely observed (age <40, single episode, no risk factors). 1, 2

References

Guideline

Differential Diagnosis of Hematospermia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Evaluation and treatment of hematospermia.

American family physician, 2009

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.